Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Visceral Leishmaniasis”

65 trials

Showing 20 of 65 results

Post-approval studies (Phase 4)Study completedNCT03311607
What this trial is testing

Safety and Effectiveness of Short-course AmBisome in the Treatment of PKDL in Bangladesh

Who this might be right for
Post-kala-azar Dermal Leishmaniasis
Medecins Sans Frontieres, Netherlands 280
Early research (Phase 1)Study completedNCT02071758
What this trial is testing

Phase 1 LEISH-F3 + SLA-SE Vaccine Trial in Healthy Adult Volunteers

Who this might be right for
Visceral Leishmaniasis
Access to Advanced Health Institute (AAHI) 39
Early research (Phase 1)Study completedNCT03929016
What this trial is testing

Single Oral Dose Escalation Study of DNDI-0690 in Healthy Subjects

Who this might be right for
Visceral LeishmaniasisCutaneous Leishmaniases
Drugs for Neglected Diseases 64
Testing effectiveness (Phase 2)Study completedNCT00371995
What this trial is testing

Short Course of Miltefosine and Liposomal Amphotericin B for Kala-azar

Who this might be right for
Visceral Leishmaniasis
Banaras Hindu University 150
Large-scale testing (Phase 3)Study completedNCT00523965
What this trial is testing

Combination Therapy in Indian Visceral Leishmaniasis

Who this might be right for
Leishmaniasis, Visceral
Banaras Hindu University 624
Testing effectiveness (Phase 2)Active Not RecruitingNCT05593666
What this trial is testing

A Phase II, Multicentre, Randomized, Two-arm Blinded Study to Assess the Efficacy and Safety of Two LXE408 Regimens for Treatment of Patients With Primary Visceral Leishmaniasis

Who this might be right for
Primary Visceral Leishmaniasis
Drugs for Neglected Diseases 101
Not applicableUnknownNCT05386875
What this trial is testing

Evaluation to Assess the Usability of rK28 for the Diagnosis of Visceral Leishmaniasis in Kenya

Who this might be right for
Visceral Leishmaniasis
Foundation for Innovative New Diagnostics, Switzerland 625
Not applicableEnded earlyNCT02839603
What this trial is testing

Asymptomatic Leishmania Infection in HIV Patients

Who this might be right for
Visceral Leishmaniasis
Institute of Tropical Medicine, Belgium 540
Not applicableStudy completedNCT04003532
What this trial is testing

LAMP Assay for the Diagnosis of Visceral Leishmaniasis

Who this might be right for
Visceral Leishmaniasis
Prof. Dawit Wolday 500
Not applicableStudy completedNCT00318721
What this trial is testing

Efficacy, Acceptability and Cost-effectiveness of Long Lasting Insecticide Nets (LLIN) in the Prevention of Kala Azar

Who this might be right for
Visceral LeishmaniasisKala Azar
London School of Hygiene and Tropical Medicine 20,000
Not applicableLooking for participantsNCT05602610
What this trial is testing

Clinical Prognostic Score to Predict Relapse in VL

Who this might be right for
Visceral Leishmaniasis
Institute of Tropical Medicine, Belgium 741
Not applicableLooking for participantsNCT07487350
What this trial is testing

Recurrent Visceral Leishmaniasis in HIV Co-Infection

Who this might be right for
HivVisceral Leishmaniasis
Institute of Tropical Medicine, Belgium 20
Large-scale testing (Phase 3)Study completedNCT03129646
What this trial is testing

Miltefosine/Paromomycin Phase III Trial for Treatment of Primary Visceral Leishmaniasis (VL) Patients in Eastern Africa

Who this might be right for
Visceral Leishmaniasis
Drugs for Neglected Diseases 439
Large-scale testing (Phase 3)Study completedNCT02011958
What this trial is testing

Efficacy Trial of Ambisome Given Alone and Ambisome Given in Combination With Miltefosine for the Treatment of VL HIV Positive Ethiopian Patients.

Who this might be right for
Visceral Leishmaniasis
Drugs for Neglected Diseases 59
Post-approval studies (Phase 4)Study completedNCT01975051
What this trial is testing

Explore Association of Treatment Regimens for Visceral Leishmaniasis, Host Immunological, Genetical and Nutrition Factors With Post-kala-azar Dermal Leishmaniasis (PKDL)

Who this might be right for
Post-kala-azar Dermal Leishmaniasis
International Centre for Diarrhoeal Disease Research, Bangladesh 36
Large-scale testing (Phase 3)Study completedNCT02193022
What this trial is testing

Miltefosine for Children With PKDL

Who this might be right for
Post Kala Azar Dermal Leishmaniasis
International Centre for Diarrhoeal Disease Research, Bangladesh 80
Not applicableStudy completedNCT00342823
What this trial is testing

Immunogenetics of Visceral Leishmaniasis

Who this might be right for
Visceral Leishmaniasis
National Human Genome Research Institute (NHGRI) 7,000
Large-scale testing (Phase 3)Study completedNCT00628719
What this trial is testing

Single Infusion of Liposomal Amphotericin B in Indian Visceral Leishmaniasis

Who this might be right for
Visceral Leishmaniasis
Banaras Hindu University 400
Not applicableLooking for participantsNCT04020536
What this trial is testing

Real World Study of Classic Infectious Disease

Who this might be right for
BrucellosesEpidemic Hemorrhagic FeverKala-Azar
Huashan Hospital 10,000
Not applicableUnknownNCT05426577
What this trial is testing

Evaluation of Less Invasive Procedures for Visceral Leishmaniasis Treatment Efficacy Monitoring Test of Cure

Who this might be right for
Visceral Leishmaniasis
Foundation for Innovative New Diagnostics, Switzerland 60
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation